Skip To The Main Content

2018 PDA Biopharmaceuticals Conference

Apr 17 - Apr 18, 2018
Seoul, Korea

From Drug Substance Manufacturing to Final Product

  • Conference
  • Europe
  • The Americas
  • Asia-Pacific
Closed
Program Highlights

Registration is still available onsite at the Conference!

Overview

The Program Planning Committee, PDA’s Korea Chapter, and PDA invite you to participate in an exciting Conference, 2018 PDA Biopharmaceuticals Conference, Apr. 17-18 in Seoul, Korea.

The goal of this Conference is to give a broad overview on biopharmaceuticals, focusing on important aspects of drug substance and drug product. Topics to be covered include:

  • Update on regulations and regulatory inspections
  • Facility concepts for pharmaceutical manufacturing processes
  • Single-use systems and next-generation processing
  • Contamination control clean rooms and aseptic areas
  • Aseptic processing and fill-finish operations
  • IPCs and final product testing
  • Primary packaging and devices especially for biopharmaceuticals, including the relevant test procedures

Industry and regulatory experts will  discuss trends in the biopharmaceutical field, and the regulatory and technical impact of these trends will be detailed. The challenges of commercialization of biosimilars in a competitive global environment will also be addressed.

Presentations will focus on practical technological aspects, using case studies as examples. There will also be a an exhibition showcasing the latest in equipment and services.

Throughout the Conference, there will be plenty of time for questions and in-depth discussion, as well as networking opportunities with experts and colleagues.

To further your learning experience, immediately after the Conference, PDA will host training courses on cleaning and disinfection, primary packaging, and devices.

We are looking forward to seeing you in Seoul!

Ask a Question

Agenda

  • Tuesday, April 17

    8:00 – 18:30 | Registration Open

    9:00 – 10:30 | P1: Opening Plenary: Regulatory Updates
    The pharmaceutical industry is a regulated industry; therefore, assessors and inspectors of health authorities are important partners of the industry. This session will address the draft EU/PIC/S Annex 1 and international regulatory developments.

    Moderator: Georg Roessling, PhD, Senior Consultant, Business Development, PDA

    9:00 | Welcome and Opening Remarks
    Woo-Hyun Paik, PhD, President, PDA Korea Chapter

    9:15 | Current Issues on GMP Inspections and the New Annex 1
    Regulatory Representatives Invited

    9:45 | Process Validation – A New Perspective: Updates from PDA TR42: Process Validation of Biopharmaceutical Drug Substance Manufacturing
    Udesh de Silva,     Lead Scientist, Samsung Biologics
     
    10:15 | Questions and Answers/Discussion

    10:30 – 11:00 | Refreshment Break in Exhibit Area

    11:00 – 13:00 | P2: Trends in Biopharmaceuticals
    This session will describe the current environment of biopharmaceuticals from a research and development, manufacturing, and regulatory perspectives. Innovator products and biosimilars, make or buy: what are technical and commercial challenges and what options are possible.

    Moderator: Georg Roessling, PhD, Senior Consultant, Business Development, PDA

    11:00 | Trends in Biopharmaceuticals: Impact on Drug Development and Commercialization
    Marie-Liesse Le Corfec, Director, Global Marketing, PFS, BD

    11:30 | Data Integrity Integration and the Power of ALCOA
    Nick Beaumont, MBA, Vice President, Quality and Compliance, Samsung Biologics

    12:00 | Pharmaceutical Facilities: Flexibility by Design Options for Incorporating Flexibility in the Conceptual Design Phase
    Morten Munk, Global Technology Partner, NNE

    12:30 | Questions and Answers/Discussion

    13:00 – 14:00 | Networking Luncheon

    14:00 – 16:00 | P3: Single-Use Systems (SUS) and Their Role in Manufacturing
    This session will give an overview of PDA Technical Report No. 66: Application of Single-Use Systems in Pharmaceutical Manufacturing and gives practical examples on how to make use of SUS and what challenges need to be considered. From vendor to user, physical and chemical properties; in use tests.

    Moderator: Nick Beaumont, MBA, Vice President, Quality and Compliance, Samsung Biologics

    14:00 | PDA Technical Report on Single-Use Systems
    Morten Munk, Global Technology Partner, NNE

    14:30 | Next Generation Technologies to Support Downstream Process Intensification
    Takao Ito, Head of Manufacturing Sciences & Technology (MSAT) Japan and Korea, Process Solutions, Merck Ltd, Japan

    15:00 | Extractables and Leachables: What Needs to be Considered When Using SUS
    Karen Pieters, Team Responsible Extractables and Leachables, Nelson Laboratories, LLC

    15:30 | Questions and Answers/Discussion

    16:00 – 16:30  | Refreshment Break in Exhibit Area

    16:30 – 18:30 | P4: Aseptic Processing and Fill Finish Operations
    The session will address the environment and equipment of aseptic processing and manufacturing. After starting with challenges of bacterial contamination and the avoidance by proper cleaning and disinfection the session will next address the technical and methodical solutions of fill finish operations. Presentations will also address the latest developments and approaches to qualify filling lines with high flexibility and short change-over times. Concepts regarding bulk primary packaging and ready-to-use containers, highly modular lines in barrier systems for liquid, and freeze-dried products will be presented.

    Moderator: Morten Munk, Global Technology Partner, NNE

    16:30 | Fungal and Bacterial Spore Excursion: Case Studies
    Jim Polarine, MA, Senior Technical Service Manager, STERIS Corporation

    17:00 | Challenges and Solutions to Fill Biopharmaceuticals
    Markus Hoersch, Sales and Marketing Director, Bausch + Ströbel

    17:30 | Case Study: Multi-Format Flexible Filling Line Isolator for All Containers – Design, Workflow, and Validation Approach
    Sergio Mauri, MSc, Director, Marketing and Business Intelligence, Fedegari Group

    18:00 | Questions and Answers/Discussion

    Wednesday, April 18

    7:30 – 17:00 | Registration Open

    8:00 – 10:00 | P5: IPC and Final Product Testing
    A manufacturing process and a fill finish operation should be validated with in-process controls which ensure that the process leads to a reliable quality which meet a specification. The presentations in this session will address methods on container closure integrity and applications of head space analytics. Methods which are preferable quantitative, fast and reliable.

    Moderator: Markus Hoersch, Sales and Marketing Director, Bausch + Ströbel

    8:00 | Material Transfer into RABS and Isolators
    Matthias Angelmaier, Product Management Pharma Liquid (PA-PH/PRM12), Robert Bosch Packaging Technology GmbH

    8:30 | CCIT Technology and 100% Inspection Supporting USP <1207>
    Jaime Cobo Vélez, Sales and Marketing Director, Wilco AG

    9:00 | Head Space Applications in Pharma
    Derek Duncan, PhD, Director and Vice President, Marketing, LIGHTHOUSE Instruments

    9:30 | Questions and Answers/Discussion

    10:00 – 10:30  | Refreshment Break in Exhibit Area

    10:30 – 12:30 | P6: Primary Packaging
    Primary packaging is an essential part of a pharmaceutical product; it is needed to ensure quality of the product over shelf life but also the type of container (vial, syringe cartridge or ampoule) is important for the convenience of patient use. Two presentations will address what needs to be considered when filling especially biopharmaceutical products. As materials there are glass and polymer available.

    Moderator: Thomas Schoenknecht, PhD, Executive Director, Business Development, SHL Group AB

    10:30 | How to Mitigate and Control Biodrug Challenges for Glass Primary Packaging: A Manufacturing Approach
    Alessandro Morandotti,Product Manager, Ompi – Stevanato Group

    11:00 | Polymer-based prefillable syringes designed to minimize the aggregation risk of sensitive biodrugs
    Philippe Lauwers, Director, Technology Development, Terumo Europe N.V.

    11:30 | Silicone Oil-Related Challenges for Biopharmaceuticals and Potential Solutions
    Sebastien Jouffray, Director, R&D, PDL, BD

    12:00 | Questions and Answers/Discussion

    12:30 – 13:30  | Networking Luncheon in Exhibit Area

    13:30 – 15:00 | P7: Devices
    Most modern biopharmaceuticals use pre-filled syringes or cartridges, which are assembled in a device, autoinjector, pen system, or more sophisticated system (e.g., for freeze-dried products). The presentations in this session will address the tests to be performed to ensure a successful and reliable assembly of primary container and device. Development strategies for devices and technical challenges for a successful introduction into the market will also be discussed. Finally, advantages for patients using devices will be highlighted, especially focusing on the very competitive environment for biosimilars.

    Moderator: Tony Ye, MA, Business Director, BD

    13:30 | How to Test Primary Containers and Assembled Devices for Parenteral Drug Delivery
    Erik Berndt, Industry Manager, Medical/Pharmaceutical, Zwick GmbH & Co KG

    14:00 | Device Development and Lifecycle Management In Modern Drug Delivery: Options To Differentiate with A Market-Accepted Platform
    Thomas Schoenknecht, PhD, Executive Director, Business Development, SHL Group AB

    14:30 | Questions and Answers/Discussion

    15:00 – 15:30 | Refreshment Break in Exhibit Area

    15:30 – 17:15 | P8: Product Development with a Pre-Filled Syringe
    For modern biopharmaceutical products it is most important to consider aspects of patient convenience of the drug application. This should be considered as part of the development and life cycle management of the drug. This session will give examples about what and how it can be achieved. 

    Moderator: Thomas Schoenknecht, PhD, Executive Director, Business Development, SHL Group AB

    15:30 | Product Development with a Pre-Filled Syringe
    Michael Vetter, Strategic Market Development, Vetter Pharma International GmbH

    16:00 | Competitive Advantage for Biosimilars through Combination Products and Lifecycle Management
    Tony Ye, MA, Business Director, BD

    16:30 | Questions and Answers/Discussion

    17:00 | Closing Remarks from Conference Chair
    Georg Roessling, PhD, Senior Consultant, Business Development, PDA

Additional Information

  • Who Should Attend

    More information coming soon.

Got a Question? We have answers

Contact Us

Travel

PLEASE READ  PDA is not affiliated or contracted with any outside hotel contracting company. If someone other than PDA or the PDA chosen hotel contacts you suggesting that they represent any PDA event, they do not. It is PDA's recommendation that you book your hotel directly through the official PDA chosen hotel that is listed on our web site.

Imperial Palace Seoul

640 Eonju-ro, Nonhyeon-dong, Gangnam-gu
Seoul, Korea

Imperial Palace Seoul
640 Eonju-ro
Nonhyeon-dong
Gangnam-gu
Seoul, Korea 06098
Tel: 82 2 3440 8000
Website

Rate: KRW 160,000++ - Guestroom rate includes (1) breakfast and internet access and is subject to 10% service charge and 11% government tax each night. 

Amenities

Imperial Palace Seoul features luxurious European styling and the latest in technology to offer a comfortable and convenient place to work and rest. Imperial Palace Seoul is located in the heart of the business and cultural center, Seoul, South Korea’s thriving capital, and it has long been a city landmark. A noble and artistic atmosphere with elegant European style interior, antiques and paintings, Imperial Palace Seoul provides a space to enjoy beautiful art beyond the function of accommodation by offering the best service and giving top priority to customer satisfaction and impression under the motto of ‘The Best of Everything’. Developing its 26-year history with pure domestic capital as the best hotel brand with a world class network along with ‘Imperial Palace City Hotel Fukuoka’ in Japan in 2007 and ‘Imperial Palace Boutique Hotel’ in Itaewon, Korea in early 2010.

Renowned ‘close service’ of Imperial Palace Seoul valuing customer satisfaction first has been improved through a service training program (A.S.S.A) since 1996. The hotel has tried to provide satisfactory service to guests through seat-style front desk, one-to-one escort service from front to guestroom, knee service at restaurants, and free valet parking service for women.

Airport

Incheon International Airport (ICN) is located 65 km (approx. 1 hour) from Imperial Palace Seoul.

How to Get Here

By Air

More information coming soon.

By Car

More information coming soon.

Other Options

More information coming soon.

Directions

Registration Fees

Regular Price

Conference Registration | April 17-18

Member

By March 30, 2018
$670

After March 30, 2018
$895

Non-member

By March 30, 2018
$895

After March 30, 2018
$1,195

Government/Health Authority/Academic

Member

By March 30, 2018
$300

After March 30, 2018
$400

Non-member*

By March 30, 2018
$300

After March 30, 2018
$400

Student

Member

By March 30, 2018
$110

After March 30, 2018
$150

Non-member*

By March 30, 2018
$110

After March 30, 2018
$150

Young Professional Member †

Member

By March 30, 2018
$300

After March 30, 2018
$415

One Day Only Fee

Tuesday/Wednesday Only

Member

By March 30, 2018
$420

After March 30, 2018
$560

Non-member*

By March 30, 2018
$500

After March 30, 2018
$665

All prices in US dollars.

* For this member type or discounted rate, online registration is not available and must be faxed in.

† You must be a member to take advantage of this rate.

Please note: In order to receive the prevailing registration rate, your registration(s) must be received by PDA by 5:00 p.m. ET on or before the date noted.

Please read PDA's confirmation, substitution, refund, and photo release policies for this workshop and course.

Group Registration Discount

Register 3 people from the same organization as a group (at the same time) for the Conference or Workshop and receive the 4th registration free. Other discounts cannot be applied.

Special Dietary Requirements

Please let us know if you have any special dietary requirement we may assist you with. Please contact us at [email protected] for help.

CONFIRMATION: A letter of confirmation will be sent to you once payment is received. You must have this written confirmation to be considered enrolled in a PDA event. Please allow one week for receipt of confirmation letter. If you have submitted a purchase order or requested an invoice please be advised that a credit card guarantee is needed. Please be advised that if your payment or written cancellation notice is not received by March 30, 2018 your credit card will be charged the prevailing rate.

SUBSTITUTIONS: If you are unable to attend, substitutions can be made at any time, including onsite for a fee of $200. If you are a non-member substituting for a member, you will be required to pay the difference non-member fee. If you are pre-registering as a substitute attendee, indicate this on the registration form.

REFUNDS: Refund requests must be in writing and faxed to +1 (301) 986-1093. (Emails and phone messages are not accepted). Refunds for Full Conference, Workshops and Events: If your written request in received on or before March 30, 2018, you will receive a full refund minus a $200 processing fee. After that time, no refunds or credit requests will be approved. Onsite registrants are not guaranteed to receive Conference materials until all advanced registered attendees receive them. PDA reserves the right to modify the material or speakers/instructors without notice or to cancel an event. If an event must be canceled, registrants will be notified by PDA in writing as soon as possible and will receive a full refund. PDA will not be responsible for airfare penalties or other costs incurred due to cancelation. For more details, contact PDA at [email protected] or +1 (301) 656-5900.

PLEASE NOTE: Photo ID will be required in order to pick up badge materials on-site. This important security procedure will prevent anyone other than the registrant from picking up their badge and materials.

RECORDING/PHOTO RELEASE: By registering for these events, I authorize PDA to record and photograph me and to use the recordings/photographs in all formats and media for any purpose, including for education, marketing and trade purposes. I hereby release PDA from all claims arising out of the use of the recordings/photographs, including without limitation all claims for compensation, libel, invasion of privacy or violation of copyright ownership. Tape recordings are prohibited at all PDA Conferences.

Group Registration Discount: Register 3 people from the same organization as a group (at the same time) for the event and receive the 4th registration free. Other discounts cannot be applied.

GENERAL TERMS AND CONDITIONS: PDA will send you a confirmation letter within one week of payment being received. You must have this confirmation letter to be considered enrolled in a PDA event. If you have submitted a purchase order or requested an invoice, please be advised that a credit card guarantee is needed. PDA reserves the right to modify the material or speakers/trainers without notice or to cancel an event. If an event is cancelled, registrants will be notified by PDA immediately and will receive a credit (registration fee paid). PDA will not be responsible for any costs incurred by registrants due to cancellation. Please note that the attendee list is shared with attendees, trainers, and exhibitors and may be used to follow up on specific areas of interest after the event. Video, photo, and audio recordings are prohibited at all PDA events.

CANCELLATION: If a cancellation request is received 30 days before the event, a credit (registration fee paid minus a 200.00 USD/EUR processing fee) will be given. No credits will be given for cancellation requests received less than 30 days before the event. Cancellation requests must be emailed to [email protected].

Sponsors

Become a Sponsor

Interested in becoming a sponsor? Learn about opportunities and benefits.

Request Information

Featured Exhibitors

Attendee List Email Scam

Unfortunately, emails are circulating that offer to sell attendee lists for many of PDA’s conferences and events. These emails are sent by scammers.

Note: PDA does not sell its exhibitor or attendee lists, and no third-party is authorized to distribute or sell any lists related to our events. Statements claiming to offer our attendee lists are fraudulent. If you receive emails that propose to sell PDA conference attendee lists, do not engage with the sender and delete the message immediately.

Become an Exhibitor

Interested in becoming an exhibitor? Learn about opportunities and benefits.

Request Information
Exhibitor Standard Contract Clause

Media Partners

Related Events

Related Events

Contact

Program Inquiries
Exhibition Inquiries
Training Course Inquiries

Tel: +1 (301) 656-5900
[email protected]

Tel: +49 (0) 30 43 655 08-10
[email protected]

Registration Customer Care

Tel: +1 (301) 656-5900 ext. 115
[email protected]

PDA Members Save Substantially